SBI Securities
MBX icon

SBI Securities’s MBX Biosciences MBX Stock Holding History

SBI Securities’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.47K Buy
+25
New +$1.56K ﹤0.01% 2720
2026
Q1 		– Sell
-9
Closed -$284 – 4178
2025
Q4 		$284 Buy
+9
New +$218 ﹤0.01% 3092

Other funds holding MBX

Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.61B AUM 22.22% 1-Year Est. Return
Koa Wealth Management
Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

SBI Securities's MBX Position: Q3 2026 in Review

SBI Securities opened a new position in MBX Biosciences (MBX) in Q3 2026: 25 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #2720 among its holdings. This is a return to the name: SBI Securities previously reported a position in MBX as recently as Q4 2025.

SBI Securities first reported a position in MBX in Q4 2025 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • SBI Securities held 25 shares of MBX Biosciences worth $1.47K as of Q3 2026.
  • MBX Biosciences was a new SBI Securities position in Q3 2026.
  • MBX Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2720 holding.
  • SBI Securities first reported a position in MBX Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.